Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens is set to host its annual Localization Summit on February 22, aiming to connect diverse local vendors with its merchandising team. This virtual event, organized with RangeMe and ECRM, allows suppliers to showcase their products, seeking opportunities to be stocked in Walgreens stores across the U.S., including Puerto Rico and the District of Columbia. The initiative targets various categories like grocery, household, and apparel, focusing on enhancing local product relevance and community engagement.
Walgreens has announced the extension of its Same Day Delivery service, now offering 24-hour delivery in various markets across the U.S. Customers can order over 27,000 items, including groceries and personal care products, accessible anytime. This initiative is designed to enhance customer convenience during the holiday season. To celebrate, Walgreens offers free delivery on orders of $20 or more through Dec. 10, 2022. The company continues to innovate with services like 30-Minute Pickup Guarantee and same-day prescription delivery.
Walgreens Boots Alliance (Nasdaq: WBA) in collaboration with VillageMD has announced the opening of the first Village Medical at Walgreens primary care practice in Las Vegas. This initiative aims to provide coordinated primary care and pharmacy services, addressing healthcare access issues highlighted by a recent survey showing that 65% of Nevadans worry about healthcare costs. The new practice will create over 45 full-time jobs and is part of a plan to expand to 200 locations across the U.S. by year-end.
Walgreens Boots Alliance (WBA) is enhancing its commitment to diversity by redesigning its annual bonus plan to include a disability representation metric, marking it as the first in the S&P 500 to do so. This initiative aims to improve the hiring and retention of people with disabilities, addressing significant barriers to employment. Furthermore, WBA has partnered with Neurodiversity in the Workplace to support the recruitment of neurodiverse talent. These efforts follow WBA’s established programs for disability inclusion, reaffirming its leadership in this space.
Walgreens Boots Alliance has initiated an offering of 10 million shares of AmerisourceBergen Corporation stock, alongside a concurrent $500 million share repurchase by AmerisourceBergen. Post-offering, Walgreens' stake in AmerisourceBergen will decrease from 26% to 20%. The proceeds will predominantly be used for debt paydown and to support strategic priorities, including acquisitions.
VillageMD has entered a definitive agreement to acquire Summit Health-CityMD for approximately $8.9 billion, with investments from Walgreens Boots Alliance (WBA) and Cigna (CI). This acquisition aims to enhance integrated healthcare offerings and create a multi-payor platform for quality, affordable care. WBA will invest $3.5 billion to support the acquisition, raising its U.S. Healthcare sales goal for fiscal year 2025 to $14.5 billion to $16.0 billion. The transaction is expected to close in Q1 2023.
Walgreens is celebrating Diabetes Awareness Month by offering complimentary diabetes services from November 9-16. These services include free A1C and blood glucose testing, along with educational support at various locations. The company has trained over 20,000 pharmacists to assist patients with diabetes management. Currently, 96 million American adults have prediabetes, and more than 37 million have diabetes. Walgreens aims to provide accessible healthcare solutions and an extensive range of diabetes-related products and services, reinforcing its commitment to the diabetes community.
Walgreens announced an agreement to settle opioid-related lawsuits for approximately $4.95 billion over 15 years. This settlement aims to resolve claims made by states, subdivisions, and tribes, without admitting liability. The company highlighted its commitment to addressing the opioid crisis through various initiatives, including patient education and availability of Naloxone. The frameworks are designed to allow Walgreens to focus on customer health and wellbeing while contributing positively to the ongoing crisis.
Western Union (NYSE: WU) and Walgreens (NASDAQ: WBA) announced a renewed five-year agreement, allowing customers to access Western Union's Money Transfer and bill payment services at approximately 9,000 Walgreens locations across the U.S. This partnership reflects both companies' commitment to delivering convenient financial services. Western Union's global network enables fast money transfers, enhancing customer engagement. The collaboration highlights Western Union's ongoing investment in expanding its omni-channel product offerings to meet diverse consumer financial needs.
Summary not available.